Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · IEX Real-Time Price · USD

5.85

+0.04 (0.69%)

At close: Jul 19, 2024, 4:00 PM

5.77

-0.08 (-1.37%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Pasithea Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0	0	0	0.02	0
Cost of Revenue	0	0	0	0.02	0
Gross Profit	0	0	0	-0	0
Selling, General & Admin	8.05	7.88	9.92	4.51	0.04
Research & Development	8.75	8.1	2.67	0	0
Operating Expenses	16.81	15.98	12.59	4.51	0.04
Operating Income	-16.81	-15.98	-12.59	-4.51	-0.04
Interest Expense / Income	0	0	0	0	0
Other Expense / Income	-0.52	-0.02	1.35	-2.33	-
Pretax Income	-16.28	-15.96	-13.94	-2.17	-0.04
Net Income	-16.28	-15.96	-13.94	-2.17	-0.04
Shares Outstanding (Basic)	1	1	1	1	0
Shares Outstanding (Diluted)	1	1	1	1	0
Shares Change	-20.03%	-2.83%	142.65%	41.29%	-
EPS (Basic)	-13.91	-13.01	-11.03	-4.20	-
EPS (Diluted)	-13.91	-13.01	-11.03	-4.20	-
Free Cash Flow	-13.8	-12.74	-12	-3.2	-0.04
Free Cash Flow Per Share	-13.24	-10.39	-9.51	-6.14	-0.10
Gross Margin	-	-	-	-14.69%	-
Operating Margin	-	-	-	-29925.73%	-
Profit Margin	-	-	-	-14430.49%	-
Free Cash Flow Margin	-	-	-	-21216.05%	-
EBITDA	-15.64	-15.31	-13.93	-2.17	-0.04
EBITDA Margin	-	-	-	-14417.97%	-
Depreciation & Amortization	0.65	0.65	0.01	0	0
EBIT	-16.28	-15.96	-13.94	-2.17	-0.04
EBIT Margin	-	-	-	-14427.12%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).